Session 16: Protein and Peptide Drug Development

Session Chair: Dr. Anton Fliri , Research Fellow, Pfizer Inc, USA
Co-Chair: Dr. W.I.M. Van de Ven, Professor, Laboratory for Molecular Oncology, Department of Human Genetics, Belgium

Title: Analytical Challenges in Protein Therapeutics Development
Dr. Xing Wang, Senior Principal Scientist, Global Biologics, Pfizer Global Research and Development, USA

Title: GEP: a Novel Chondrogenic Growth Factor and Target in Arthritis
Dr. Chuanju Liu, Assistant Professor, Dept. of Orthopaedic Surgery & Cell Biology, New York University School of Medicine, USA

Title: Furin: A Proven Endoproteolytic Processing Tool for Enhanced Manufacturing of Safe Recombinant Biopharmaceuticals
Dr. W.J.M. Van de Ven, Professor, Laboratory for Molecular Oncology, Department of Human Genetics, Belgium

Title: MED-SuMo : A Powerful Software to Classify Binding Sites Using 3D Surface Chemical Features and to Perform Fragment-Based Drug Design at PDB Scale
Dr. Alexandre G. de Brevern, French Institute of Health and Medical Research, France

Title: Studies on the Origin of Protein Network Topologies
Dr. Anton Fliri, Research Fellow, Pfizer Inc, USA

Title: Ribosomal synthesis of unusual peptides by reprogramming the genetic code and its application for physiologically stable peptide drugs
Dr. Hiroaki Suga, Research Center for Advanced Science and Technology, The University of Tokyo, Japan

Title: In vivo Regulation and Inhibition of Ribonucleotide Reductase
Dr. Mingxia Huang, University of Colorado Health Sciences Center, USA

Title: Molecular Designer Of Self-assembling Peptide Nanomaterials and Its Application In Regenerative Medicine
Dr. Xiaojun Zhao, Professor and Executive Director, Institute for Nanobiomedical Technology and Membrane Biology, Sichuan University, Chengdu, China
©2004-2007 All right reserved for IDDST
IDDST-2007 is sponsored by BIT, Tel: 86-411-84799609, Fax: 86-411-84799629